[{"id":"5064553d-e4ed-498f-bc5e-f6c9536a84d7","acronym":"CSG-1906-101","url":"https://clinicaltrials.gov/study/NCT05857332","created_at":"2023-05-12T17:05:01.178Z","updated_at":"2024-07-02T16:35:28.556Z","phase":"Phase 1","brief_title":"SG1906 for CLDN18.2-Positive Solid Tumors","source_id_and_acronym":"NCT05857332 - CSG-1906-101","lead_sponsor":"Hangzhou Sumgen Biotech Co., Ltd.","biomarkers":" CLDN18","pipe":" | ","alterations":" CLDN18.2 positive","tags":["CLDN18"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CLDN18.2 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e SG1906"],"overall_status":"Recruiting","enrollment":" Enrollment 60","initiation":"Initiation: 05/30/2023","start_date":" 05/30/2023","primary_txt":" Primary completion: 02/28/2025","primary_completion_date":" 02/28/2025","study_txt":" Completion: 08/30/2025","study_completion_date":" 08/30/2025","last_update_posted":"2023-11-21"}]